- OptiBiotix Health said it had entered into a three year distribution agreement with a company it didn't name to exclusively distribute its weight loss medical devices in Greece and Cyprus.

The agreement also granted the company a first right of refusal for the Gulf States, in return for meeting annual sales targets to retain exclusivity.

'We are pleased to announce this exclusive distribution deal so soon after achieving medical device registration and CE mark for SlimBiome,' chief executive Stephen OHara said.

'Even more encouraging is that the company has placed an early order and expects to make further orders to support a consumer launch in early 2019.'

At 9:10am: [LON:OPTI] Optibiotix Health Plc share price was -0.4p at 98.6p

Story provided by